Which Is the Most Suitable and Effective Route of Administration for Mesenchymal Stem Cell-Based Immunomodulation Therapy in Experimental Kidney Transplantation: Endovenous or Arterial?

Which Is the Most Suitable and Effective Route of Administration for Mesenchymal Stem Cell-Based Immunomodulation Therapy in Experimental Kidney Transplantation: Endovenous or Arterial?
复制标题

DOI:
10.1016/j.transproceed.2010.03.081
复制
发表时间:
2010-05-01
影响因子:
0.9
通讯作者:
Alessiani, M.
Alessiani, M.
中科院分区:
医学4区
文献类型:
--
作者:
Zonta, S.;De Martino, M.;Alessiani, M.

文献摘要

被引文献

相似文献

免疫调节细胞治疗代表了一个新的观点,控制细胞免疫反应,决定发生急性排斥反应(ACR)在同种异体移植。间充质干细胞(MSC)通过灭活在移植模型中调节组织损伤的T细胞成分来显示免疫调节作用。推测的作用机制是细胞因子网络募集细胞。本研究的目的是测试哪种给药途径(动脉内与静脉内)是在实验性大鼠肾移植中实现免疫调节作用的最有效途径。将在体细胞水平表达增强型绿色荧光蛋白(EGFP)的转基因Sprague-Dawley大鼠(SD)用作MSC供体:在双侧肾切除术后对大鼠进行异基因Fischer至刘易斯移植(每组n = 4)。在Gr B中,将3 × 10(6)MSC输注到移植肾动脉中,而在Gr C中,将它们输注到尾静脉中。未处理的Gr A为对照组。未给予免疫抑制治疗。术后第7天处死动物。对移植动物进行肾功能的生化分析、组织学(Banff标准)和免疫组织学(抗EGFP-免疫球蛋白)分析。在B组中,功能恢复更快(肌酐:B组vs C组,P <0.05)。移植物中的炎性浸润在Gr B组比Gr C组少,保留了肾小管、动脉和肾小球(P <0.01)。动脉内灌注骨髓间充质干细胞能更有效地控制ACR。
Immunomodulating cell therapy represents a new perspective for the control of cellular immune responses that determine the occurrence of acute rejection (ACR) in allotransplantation. Mesenchymal stem cells (MSC) demonstrate immunoregulatory effects by inactivating T-cell components that regulate tissue damage in transplantation models. The presumed mechanism of action is recruitment of cells by a cytokine network. The purpose of this study was to test which route of administartion (intra-arterial vs intravenous) was the most effective route to achieve immunomodulating effects in experimental rat kidney transplantation. Transgenic Sprague-Dawley rats (SD) expressing the enhanced green fluorescent protein (EGFP) at the somatic level were used as MSC donors: Allogeneic Fischer to Lewis grafts (n = 4 per group) were performed in rats after bilateral nephrectomy. In Gr B, 3 x 10(6) MSCs were infused into the renal graft artery, whereas in Gr C, they were infused into the tail vein. The untreated Gr A were a control group. No immunosuppressive therapy was administered. The animals were sacrificed at day 7 postoperatively. Biochemical analysis for renal function, histological (Banff criteria) and immunohistological (anti-EGFP-Immunoglobulin) analysis were performed on the transplanted animals. In Gr B, functional recovery was more rapid (creatinine: Gr B vs Gr C, P < .05). The inflammatory infiltrate in the graft was less in Gr B vs Gr C, with preservation of tubules, arteries, and glomeruli (P < .01). Intra-arterial infusion of MSCs was more effective to control ACR.